Last reviewed · How we verify

BPaQM — Competitive Intelligence Brief

BPaQM (BPaQM) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimalarial. Area: Infectious Disease.

phase 3 Antimalarial Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

BPaQM (BPaQM) — Otsuka Pharmaceutical Development & Commercialization, Inc.. BPaQM is a novel antimalarial compound that acts as a blood schizonticide to prevent malaria parasite multiplication in red blood cells.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
BPaQM TARGET BPaQM Otsuka Pharmaceutical Development & Commercialization, Inc. phase 3 Antimalarial
Coartem LUMEFANTRINE Novartis marketed Antimalarial [EPC] Potassium voltage-gated channel subfamily H member 2 2009-01-01
Coartem ARTEMETHER marketed Antimalarial [EPC] 2009-01-01
Qualaquin QUININE Sun Pharm Industries marketed Antimalarial Sodium channel alpha subunits; brain (Types I, II, III) 2005-01-01
Malarone PROGUANIL GSK marketed Antimalarial [EPC] 2000-01-01
Mepron ATOVAQUONE marketed Antimalarial [EPC] ATP-binding cassette sub-family G member 2 1992-01-01
Halfan HALOFANTRINE GSK marketed Antimalarial Potassium voltage-gated channel subfamily H member 2 1992-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimalarial class)

  1. London School of Hygiene and Tropical Medicine · 6 drugs in this class
  2. Sanofi · 3 drugs in this class
  3. Epicentre · 2 drugs in this class
  4. University of Oxford · 2 drugs in this class
  5. · 2 drugs in this class
  6. Frantz Viral Therapeutics, LLC · 1 drug in this class
  7. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  8. Institut de Recherche pour le Developpement · 1 drug in this class
  9. Centre de Recherche Médicale de Lambaréné · 1 drug in this class
  10. GlaxoSmithKline · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). BPaQM — Competitive Intelligence Brief. https://druglandscape.com/ci/bpaqm. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: